Veracyte, Inc. (VCYT) — 10-Q Filings

10-Q Filings (7)

• 10-Q Filing — May 6, 2026
• Veracyte's Q3 Earnings Soar on Strong Testing Revenue Growth — Nov 5, 2025 Risk: medium
  Veracyte, Inc. (VCYT) reported a strong financial performance for the three and nine months ended September 30, 2025. Total revenue for the three months increas
• Veracyte's Revenue Jumps 15.6%, Narrows Q2 Net Loss to $15M — Aug 7, 2025 Risk: medium
  VERACYTE, INC. reported a significant increase in total revenue for the three months ended June 30, 2025, reaching $92.5 million, up from $80.0 million in the s
• Veracyte, Inc. Q1 2025 10-Q Filed — May 8, 2025 Risk: medium
  Veracyte, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 20
• Veracyte, Inc. Files Q3 2024 10-Q Report — Nov 7, 2024 Risk: medium
  Veracyte, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter o
• Veracyte, Inc. Files Q2 2024 10-Q — Aug 7, 2024 Risk: low
  Veracyte, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 20
• Veracyte, Inc. Files 10-Q for Q1 2024 — May 8, 2024 Risk: low
  VERACYTE, INC. (VCYT) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Veracyte, Inc. filed its 10-Q report for the period ending March 31, 2024. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX